Methoxymesidin | 34874-88-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: Methoxymesidin
• 英文别名: Benzenamine, 3-methoxy-2,4,6-trimethyl-；3-methoxy-2,4,6-trimethylaniline
• CAS: 34874-88-9
• 化学式: C₁₀H₁₅NO
• 分子量: 165.235
• InChiKey: QAOXQOGINGPALT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Methoxymesidin 生成 3-甲氧基-2,4,6-三甲基苯酚
  参考文献：
  名称：

  Bruun,T., Acta Chemica Scandinavica (1947), 1971, vol. 25, p. 2837 - 2851

  摘要：

  DOI：
• 作为产物：
  描述：

  2,4,6-三甲酚 在 nitronium tetrafluoborate 、 sodium hydride 、 氯化铵 、 锌 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 25.0h， 生成 Methoxymesidin
  参考文献：
  名称：

  Endothelin Antagonists:  Substituted Mesitylcarboxamides with High Potency and Selectivity for ET_A Receptors

  摘要：

  We have previously disclosed the discovery of 2,4-disubstituted anilinothiophenesulfonamides with potent ETA-selective endothelin receptor antagonism and the subsequent identification of sitaxsentan (TBC11251, 1) as a clinical development compound (Wu et al. J. Med. Chem. 1997, 40, 1682 and 1690). The orally active 1 has demonstrated efficacy in a phase II clinical trial of congestive heart failure (Givertz ct al. Circulation 1998, 98, Abstr. #3044) and was active in rat models of myocardial infarction (Podesser et al. Circulation. 1998, 98, Abstr. #2896) and acute hypoxia-induced pulmonary hypertension (Chen et al. FASEB J. 1996, 10 (3), A104). We now report that an additional substituent at the 6-position of the anilino ring further increases the potency of this series of compounds. It was also found that a wide range of functionalities at the 3-position of the 2,4,6-trisubstituted ring increased ETA selectivity by similar to 10-fold while maintaining in vitro potency, therefore rendering the compounds amenable to fine-tuning of pharmacological and toxicological profiles with enhanced selectivity. The optimal compound in this series was found to be TBC2576 (7u), which has similar to 10-fold higher ETA binding affinity than 1, high ETA/ETB selectivity, and a serum half-life of 7.3 h in rats, as well as in vivo activity.

  DOI：

  10.1021/jm9900063

文献信息

• NOVEL COMPOUND, COLORING COMPOSITION FOR DYEING OR TEXTILE PRINTING, INK JET INK, METHOD OF PRINTING ON FABRIC, AND DYED OR PRINTED FABRIC
  申请人：FUJIFILM Corporation

  公开号：US20170101533A1

  公开（公告）日：2017-04-13

  Provided are a compound represented by any one of Formulae (1) to (3) (for example, the following compound), a coloring composition for dyeing or textile printing including the compound, an ink jet ink including the coloring composition for dyeing or textile printing, a method of printing on fabric, and a dyed or printed fabric, in which the color is excellent, the color optical density is high, and light fastness, water fastness, and chlorine fastness are excellent.

  提供了由公式（1）至（3）中的任何一个表示的化合物（例如，以下化合物），包括该化合物的染色或纺织印花组合物，包括用于染色或纺织印花的染色组合物的喷墨墨水，在织物上印刷的方法，以及染色或印花织物，其中颜色优秀，颜色光密度高，耐光性、耐水性和耐氯性优秀。
• 着色組成物、インクジェット用インク、布帛を捺染する方法、及び染色又は捺染された布帛
  申请人：富士フイルム株式会社

  公开号：JP2017066208A

  公开（公告）日：2017-04-06

  【課題】耐光性に優れ、かつ貯蔵安定性に優れた着色組成物、前記着色組成物を含有するインクジェット用インク、布帛を捺染する方法、及び染色又は捺染された布帛の提供。【解決手段】式（１）等で表されるトリアリールメタン化合物を含有する着色組成物、上記着色組成物を含有するインクジェット用インク、布帛を捺染する方法、及び染色又は捺染された布帛。【選択図】なし

  这是一段关于耐光性和储存稳定性优异的着色组合物，包括含有该着色组合物的喷墨墨水，布料染色的方法，以及提供染色或印染过的布料的专利描述。解决方案包括含有三苯甲烷化合物的着色组合物，以及包含该着色组合物的喷墨墨水，布料染色的方法，以及染色或印染过的布料。【选定图】无
• Endothelin Antagonists:  Substituted Mesitylcarboxamides with High Potency and Selectivity for ET_A Receptors
  作者：Chengde Wu、E. Radford Decker、Natalie Blok、Huong Bui、Qi Chen、B. Raju、Andree R. Bourgoyne、Vippra Knowles、Ronald J. Biediger、Robert V. Market、Shuqun Lin、Brian Dupré、Timothy P. Kogan、George W. Holland、Tommy A. Brock、Richard A. F. Dixon

  DOI：10.1021/jm9900063

  日期：1999.11.1

  We have previously disclosed the discovery of 2,4-disubstituted anilinothiophenesulfonamides with potent ETA-selective endothelin receptor antagonism and the subsequent identification of sitaxsentan (TBC11251, 1) as a clinical development compound (Wu et al. J. Med. Chem. 1997, 40, 1682 and 1690). The orally active 1 has demonstrated efficacy in a phase II clinical trial of congestive heart failure (Givertz ct al. Circulation 1998, 98, Abstr. #3044) and was active in rat models of myocardial infarction (Podesser et al. Circulation. 1998, 98, Abstr. #2896) and acute hypoxia-induced pulmonary hypertension (Chen et al. FASEB J. 1996, 10 (3), A104). We now report that an additional substituent at the 6-position of the anilino ring further increases the potency of this series of compounds. It was also found that a wide range of functionalities at the 3-position of the 2,4,6-trisubstituted ring increased ETA selectivity by similar to 10-fold while maintaining in vitro potency, therefore rendering the compounds amenable to fine-tuning of pharmacological and toxicological profiles with enhanced selectivity. The optimal compound in this series was found to be TBC2576 (7u), which has similar to 10-fold higher ETA binding affinity than 1, high ETA/ETB selectivity, and a serum half-life of 7.3 h in rats, as well as in vivo activity.
• Bruun,T., Acta Chemica Scandinavica (1947), 1971, vol. 25, p. 2837 - 2851
  作者：Bruun,T.

  DOI：——

  日期：——